LH Laboratory Corp of America Holdings - 8-K

Item 5.07.

Submission of Matters to a Vote of Security Holders.

As of March 26, 2026, the date of record for determining the shareholders of Labcorp Holdings Inc. (the “Company”) entitled to vote on the proposals presented at the Company’s 2026 Annual Meeting of the Shareholders (the “Annual Meeting”), there were 82,187,046 shares of the Company’s common stock issued and outstanding and entitled to vote at the Annual Meeting. The holders of 76,382,627 shares of the Company’s issued and outstanding common stock were represented in person or by proxy at the Annual Meeting, constituting a quorum. The proposals presented at the Annual Meeting are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 10, 2026 (the “Proxy Statement”). The vote results detailed below represent final results as certified by the Inspector of Elections.

Proposal 1.

The Company’s shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the “Board”) to hold office for the term expiring at the 2027 Annual Meeting of Shareholders or until their successors are elected and qualified or until their earlier death, resignation, or removal:

Votes For

Votes Against

Abstentions

Broker Non-Votes

Adam H. Schechter

65,401,337

4,958,626

199,252

5,823,412

Kerrii B. Anderson

65,239,780

5,292,331

27,104

5,823,412

Victor Bulto

70,498,948

34,977

25,290

5,823,412

Jeffrey A. Davis

70,478,919

56,436

23,860

5,823,412

Kirsten M. Kliphouse

70,499,628

36,211

23,376

5,823,412

Garheng Kong, M.D., Ph.D.

50,153,535

20,110,931

294,749

5,823,412

Peter M. Neupert

65,976,598

4,555,882

26,735

5,823,412

Richelle P. Parham

67,776,302

2,757,710

25,203

5,823,412

Paul B. Rothman, M.D.

70,194,447

340,176

24,592

5,823,412

John H. Sampson, M.D., Ph.D.

70,465,205

70,221

23,789

5,823,412

Kathryn E. Wengel

70,186,853

348,897

23,465

5,823,412

Proposal 2.

The Company’s shareholders approved in an advisory (non-binding) vote, the compensation of the Company’s named executive officers. The votes regarding this proposal were as follows:

Votes For

Votes Against

Abstentions

Broker Non-Votes

66,519,291

3,735,777

304,147

5,823,412

Proposal 3.

The Company’s shareholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The votes regarding this proposal were as follows:

Votes For

Votes Against

Abstentions

Broker Non-Votes

76,291,589

53,650

37,388

—